Skip to main content

Table 5 Association of PLS3 expression with clinicopathological features in PDA patients from TCGA

From: Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma

Variables Cases (number, %) PLS3 level (number, %) P
High expression
N = 83
Low expression
N = 84
Age (years)
 ≤ 55 33 (19.8) 20 (60.6) 13 (39.4%) 0.16
 > 55 134 (80.2) 63 (47.0) 71 (53.0)
Histologic grade
 G1/G2 117 (70.1) 57 (48.7) 60 (51.3) 0.69
 G3/G4 50 (29.9) 26 (52.0) 24 (48.0)
N classification
 N0 47 (28.1) 20 (42.6) 27 (57.4) 0.24
 N1 120 (71.9) 63 (52.5) 57 (47.5)
T classification
 T1/T2 28 (16.8) 12 (42.9) 16 (57.1) 0.42
 T3/T4 139 (83.2) 71 (51.1) 68 (48.9)
Gender
 Female 76 (45.5) 37 (48.7) 39 (51.3) 0.81
 Male 91 (54.5) 46 (50.5) 45 (49.5)
Stage
 Stage I/II 160 (95.8) 79 (49.4) 81 (50.6) 0.68
 Stage III/IV 7 (4.2) 4 (57.1) 3 (42.9)